Oncolytics Biotech earnings were -$22.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ONCY earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$5.6M, down 20.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ONCY reported annual earnings of -$22.0M, with 5.5% growth. The next ONCY earnings date is May 7, 2025.
What were Oncolytics Biotech's earnings last quarter?
On ONCY's earnings call on Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q4 2024 earnings per share (EPS) of -$0.07, up 81.58% year over year. Total ONCY earnings for the quarter were -$5.57 million. In the same quarter last year, Oncolytics Biotech's earnings per share (EPS) was -$0.04.
The next ONCY earnings date is Invalid Date. Add ONCY to your watchlist to be reminded of Oncolytics Biotech's next earnings date.
What was ONCY's earnings growth in the past year?
As of Oncolytics Biotech's earnings date in Invalid Date, Oncolytics Biotech's earnings has grown year over year. ONCY earnings in the past year totalled -$22.33 million.
Is Oncolytics Biotech profitable or losing money?
As of the last Oncolytics Biotech earnings report, Oncolytics Biotech is currently losing money. Oncolytics Biotech's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$22.02 million, a 5.53% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.